Where does NEX Medical Antiseptics S.R.L. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NEX Medical Antiseptics S.R.L. ranks #49,059 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NEX Medical Antiseptics S.R.L. hold?

NEX Medical Antiseptics S.R.L. holds 5 US utility patents granted between 2018 and 2024, spanning 5 technology areas.

What is NEX Medical Antiseptics S.R.L.'s Innovation Score?

NEX Medical Antiseptics S.R.L. has an Innovation Score of 26.2 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is NEX Medical Antiseptics S.R.L.'s patent grant rate increasing or decreasing?

NEX Medical Antiseptics S.R.L.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for NEX Medical Antiseptics S.R.L.'s patents?

NEX Medical Antiseptics S.R.L.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NEX Medical Antiseptics S.R.L. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

NEX Medical Antiseptics S.R.L.

Q: What technology areas does NEX Medical Antiseptics S.R.L. focus on?

NEX Medical Antiseptics S.R.L.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 5 patents, ranking #1,311 of 3,490 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, NEX ranks #49,059 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#49,059
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.2/100): 14.6
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49059 · Foreign Corporation #49,059 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,059/49,997
PHOTO-FINISH NEW Frontier Labs
CPC-NARROW A61M · 5 areas
INNOV-THIN 26.2/100
CLAIMS-RICH 14.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: NEW Frontier Labs, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How NEX’s 26.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (24%) Velocity 3.3 pts (13%) Breadth 7.9 pts (30%) Claim depth 8.8 pts (34%)

Qualcomm Incorporated · highest

85
NEX Medical… · this assignee

26
3D Lighting… · lowest

7

What this shows NEX's Innovation Score is 26.2/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for NEX?

Each dot is one of NEX’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). NEX’s own 14.6 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

NEX vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where NEX's grants concentrate

NEX Medical Antiseptics S.R.L. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2024. By volume, NEX sits between NEW Frontier Labs, LLC and Nextpat Limited.

NEX's three-year grant acceleration

NEX Medical Antiseptics S.R.L. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

NEW Frontier Labs

5
NEW York Life Ins…

5
NEW York Medical…

5
Newteq Holding B V

5
Nexgen Composites

5
NEXO

5
Nextchem S P A

5
Nextpat

5
NEX Medical Antis… ◀

5

What this shows NEX holds 5 patents at rank #49,003, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NEX

By rank, the assignees closest to #49,003 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in NEX's primary technology class.

NEX's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

NEX Medical Antiseptics S.R.L. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	40.0%
2021	2	40.0%
2024	1	20.0%

Which technologies does NEX Medical Antiseptics S.R.L. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

A47K - Sanitary Equipment NOT Otherwise Provided FOR ; Toilet Accessories 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NEX Medical Antiseptics S.R.L.'s patent record in context - here's where to go next.

NEX Medical Antiseptics S.R.L.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #49,059 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NEX Medical Antiseptics S.R.L. against NEW Frontier Labs, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.